Vergoeding 2016-2020 voor ATC-subgroep L02BA : Anti-oestrogenen
- Raming voor de totale Zvw-populatie
| 2016 | 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|---|
| L02BA01 Tamoxifen | 1.831.700 | 1.521.700 | 1.282.600 | 1.335.100 | 1.369.000 |
| L02BA03 Fulvestrant (Faslodex ®) | 5.067.600 | 6.868.200 | 8.474.600 | 9.011.500 | 9.068.300 |
| Totaal | 6.899.300 | 8.389.900 | 9.757.200 | 10.346.600 | 10.437.300 |